E. A. Alegre-del Rey

Pembrolizumab plus Chemotherapy in Lung Cancer.

M. Garassino, MD Gil-Sierra, S. Fénix-Caballero, 2018, The New England journal of medicine.

Indirect comparison of biological treatments in refractory rheumatoid arthritis

E. A. Alegre-del Rey, M. Gallego-Galisteo, A. Villa-Rubio, 2012, Journal of clinical pharmacy and therapeutics.

Peptic disease: a confounding factor for proton pump inhibitor-clopidogrel interaction?

J. Sierra-Sánchez, E. A. Alegre-del Rey, R. Castaño-Lara, 2010, The American journal of cardiology.

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma.

M. Sánchez-Hidalgo, L. García-Mochón, MD Gil-Sierra, 2019, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

▼Tiotropium for chronic obstructive pulmonary disease

J. Sierra-Sánchez, E. A. Alegre-del Rey, Isidoro Cobo, 2003, The New England journal of medicine.

Remdesivir and mortality reduction in COVID-19 patients: a systematized subgroup analysis of clinical trials.

M. Sánchez-Hidalgo, MD Gil-Sierra, E. A. Alegre-del Rey, 2021, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis

S. Fénix-Caballero, E. A. Alegre-del Rey, R. Castaño-Lara, 2013, Journal of clinical pharmacy and therapeutics.

Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant of hematopoietic progenitor cells

L. García Mochón, D. Epstein, A. Olry de Labry Lima, 2019, Bone Marrow Transplantation.

Network meta‐analysis of tofacitinib versus biologic treatments in moderate‐to‐severe rheumatoid arthritis patients

V. Gimeno-Ballester, S. Fénix-Caballero, E. A. Alegre-del Rey, 2019, Journal of clinical pharmacy and therapeutics.

Network meta‐analysis of first‐line treatments in transplant‐ineligible multiple myeloma patients

V. Gimeno-Ballester, MD Gil-Sierra, S. Fénix-Caballero, 2020, European journal of haematology.

Use of docetaxel in low- and high-burden metastatic hormone-sensitive prostate cancer: A systematic review and assessment of subgroup analyses

M. Sánchez-Hidalgo, MD Gil-Sierra, E. A. Alegre-del Rey, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[Risk of medicines in pregnancy: a problem of knowledge transfer with ethical implications].

S. Fénix-Caballero, E. A. Alegre-del Rey, J. Díaz-Navarro, 2019, Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica.

Daratumumab-based therapies in transplant-ineligible patients with untreated multiple myeloma and hepatic dysfunction: A systematic review of subgroup analyses

M. Sánchez-Hidalgo, MD Gil-Sierra, S. Fénix-Caballero, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Checklist for clinical applicability of subgroup analysis

M. Sánchez-Hidalgo, MD Gil-Sierra, S. Fénix-Caballero, 2019, Journal of clinical pharmacy and therapeutics.